Novo Nordisk Aktie
85,65
EUR
+3,59
EUR
+4,37
%
83,42
EUR
+4,22
EUR
+5,33
%
Novo Nordisk Aktie Analyse
| 11.04.16 | Novo Nordisk Hold | Deutsche Bank AG | |
| 15.03.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 22.02.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.02.16 | Novo Nordisk Neutral | BNP PARIBAS | |
| 09.02.16 | Novo Nordisk Halten | Independent Research GmbH | |
| 04.02.16 | Novo Nordisk Neutral | UBS AG | |
| 01.02.16 | Novo Nordisk Neutral | UBS AG | |
| 14.01.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 10.12.15 | Novo Nordisk Neutral | BNP PARIBAS | |
| 01.12.15 | Novo Nordisk Halten | Independent Research GmbH | |
| 30.11.15 | Novo Nordisk Hold | Deutsche Bank AG | |
| 20.11.15 | Novo Nordisk Neutral | UBS AG | |
| 05.11.15 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.11.15 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 19.10.15 | Novo Nordisk Neutral | UBS AG | |
| 15.10.15 | Novo Nordisk Neutral | UBS AG | |
| 15.10.15 | Novo Nordisk Hold | Commerzbank AG | |
| 28.09.15 | Novo Nordisk Neutral | UBS AG | |
| 27.08.15 | Novo Nordisk Neutral | UBS AG | |
| 11.08.15 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.08.15 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 04.08.15 | Novo Nordisk Neutral | BNP PARIBAS | |
| 31.07.15 | Novo Nordisk Neutral | UBS AG | |
| 29.07.15 | Novo Nordisk Neutral | UBS AG | |
| 17.07.15 | Novo Nordisk Neutral | Credit Suisse Group | |
| 28.05.13 | Novo Nordisk halten | Deutsche Bank AG | |
| 12.02.13 | Novo Nordisk halten | Credit Suisse Group | |
| 12.02.13 | Novo Nordisk halten | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.13 | Novo Nordisk halten | S&P Equity Research | |
| 11.02.13 | Novo Nordisk halten | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.11.12 | Novo Nordisk neutral | Nomura | |
| 12.11.12 | Novo Nordisk equal-weight | Morgan Stanley | |
| 12.11.12 | Novo Nordisk neutral | Exane-BNP Paribas SA | |
| 07.11.12 | Novo Nordisk neutral | Sarasin Research | |
| 07.11.12 | Novo Nordisk neutral | Exane-BNP Paribas SA | |
| 07.11.12 | Novo Nordisk neutral | Nomura | |
| 07.11.12 | Novo Nordisk neutral | J.P. Morgan Cazenove | |
| 31.10.12 | Novo Nordisk neutral | Sarasin Research | |
| 29.10.12 | Novo Nordisk neutral | Exane-BNP Paribas SA | |
| 26.10.12 | Novo Nordisk equal-weight | Morgan Stanley | |
| 26.10.12 | Novo Nordisk neutral | Nomura | |
| 11.09.12 | Novo Nordisk neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Novo Nordisk neutral | Nomura | |
| 10.08.12 | Novo Nordisk neutral | Exane-BNP Paribas SA | |
| 09.08.12 | Novo Nordisk neutral | Sarasin Research | |
| 21.06.12 | Novo Nordisk neutral | Credit Suisse Group | |
| 08.06.12 | Novo Nordisk neutral | J.P. Morgan Cazenove | |
| 27.04.12 | Novo Nordisk neutral | Sarasin Research | |
| 02.02.12 | Novo Nordisk neutral | Sarasin Research | |
| 27.01.12 | Novo Nordisk hold | Société Générale Group S.A. (SG) | |